Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Operating Expenses | 18,062 | 0 | 13,131 | 15,516 |
| Operating Income | -18,062 | N/A | -13,131 | -15,516 |
| Interest Expense | 314 | 0 | 59 | 0 |
| Other Income | 28 | 0 | 120 | 215 |
| Pre-tax Income | -18,348 | 0 | -13,070 | -15,301 |
| Net Income Continuous | -18,348 | N/A | -13,070 | -15,301 |
| Net Income | $-18,348 | $N/A | $-13,070 | $-15,301 |
| EPS Basic Total Ops | -2.39 | N/A | -1.75 | -2.05 |
| EPS Basic Continuous Ops | -2.39 | N/A | -1.75 | -2.05 |
| EPS Diluted Total Ops | -2.39 | N/A | -1.75 | -2.05 |
| EPS Diluted Continuous Ops | -2.39 | N/A | -1.75 | -2.05 |
| EBITDA(a) | $-17,269 | $N/A | $-12,707 | $-15,516 |